BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2022 10:56:44 AM | Browse: 364 | Download: 671
 |
Received |
|
2022-07-29 13:24 |
|
Peer-Review Started |
|
2022-07-29 13:26 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-08-22 01:15 |
|
Revised |
|
2022-08-22 10:27 |
|
Second Decision |
|
2022-08-30 03:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-08-31 20:11 |
|
Articles in Press |
|
2022-08-31 20:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-16 05:51 |
|
Publish the Manuscript Online |
|
2022-09-24 10:56 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Minireviews |
| Article Title |
Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Deven Juneja, Anish Gupta, Sahil Kataria and Omender Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Deven Juneja, Visiting Professor, FCCP, MBBS, Director, Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Saket, 1 Press Enclave Road, New Delhi 110017, India. devenjuneja@gmail.com |
| Key Words |
Ascorbic acid; COVID-19; SARS-CoV-2; Vitamin C |
| Core Tip |
Vitamin C has several biochemical effects including anti-oxidant, anti-inflammatory, immuno-modulatory, and anti-viral properties which could make it a possible low-risk, add on to the current therapeutic options for managing coronavirus disease 2019 (COVID-19) patients. As it is a water-soluble vitamin, even high doses have been shown to be safe and only rarely, complications have been reported. In the last couple of years, many case series, observational studies and even randomised control trials have been conducted to evaluate the role of vitamin C in COVID-19, but have shown conflicting results. Hence, as per the current clinical evidence, the role of vitamin C remains ambiguous and it cannot be recommended as a part of routine therapeutic regimen for managing COVID-19 patients. |
| Publish Date |
2022-09-24 10:56 |
| Citation |
Juneja D, Gupta A, Kataria S, Singh O. Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview. World J Virol 2022; 11(5): 300-309 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i5/300.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i5.300 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
